Science Explorer Back to mapMap
Discussion
Institution · Eutropics Pharmaceuticals (United States)

Most cited papers from Eutropics Pharmaceuticals (United States)

Eutropics Pharmaceuticals (United States)

What are the most cited papers from Eutropics Pharmaceuticals (United States)?

The most cited paper from Eutropics Pharmaceuticals (United States) is "BCL-2 family proteins as 5-Azacytidine-sensitizing targets and determinants of response in myeloid malignancies" (James M. Bogenberger et al., 2014), with 199 citations. Next come "Inhibition of Histone Deacetylases Promotes Ubiquitin-Dependent Proteasomal Degradation of DNA Methyltransferase 1 in Human Breast Cancer Cells" (167) and "Hydroxamic Acid Analogue Histone Deacetylase Inhibitors Attenuate Estrogen Receptor-α Levels and Transcriptional Activity: A Result of Hyperacetylation and Inhibition of Chaperone Function of Heat Shock Protein 90" (141).

Showing 50 of 51 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 BCL-2 family proteins as 5-Azacytidine-sensitizing targets and determinants of response in myeloid malignancies James M. Bogenberger et al. · Leukemia Open access 23 Jan 2014 199
2 Inhibition of Histone Deacetylases Promotes Ubiquitin-Dependent Proteasomal Degradation of DNA Methyltransferase 1 in Human Breast Cancer Cells Qun Zhou, Agoston T. Agoston, Peter Wisdom Atadja et al. · Molecular Cancer Research Open access May 2008 167
3 Hydroxamic Acid Analogue Histone Deacetylase Inhibitors Attenuate Estrogen Receptor-α Levels and Transcriptional Activity: A Result of Hyperacetylation and Inhibition of Chaperone Function of Heat Shock Protein 90 Warren C. Fiskus, Yuan Ren, Alex Mohapatra et al. · Clinical Cancer Research 15 Aug 2007 141
4 89Zr-trastuzumab and 89Zr-bevacizumab PET to Evaluate the Effect of the HSP90 Inhibitor NVP-AUY922 in Metastatic Breast Cancer Patients Sietske B.M. Gaykema, Carolien P. Schröder, Joanna Vitfell-Rasmussen et al. · Clinical Cancer Research 31 Jul 2014 121
5 Targeting PI3K/mTOR Overcomes Resistance to HER2-Targeted Therapy Independent of Feedback Activation of AKT Neil A. O’Brien, K McDonald, Tong Luo et al. · Clinical Cancer Research 30 May 2014 118
6 Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cells Warren C. Fiskus, Michael Pranpat, Maria E. Balasis et al. · Molecular Cancer Therapeutics Dec 2006 112
7 Similar Exposure to a Tobacco-Specific Carcinogen in Smokeless Tobacco Users and Cigarette Smokers Stephen S. Hecht, Steven G. Carmella, Sharon E. Murphy et al. · Cancer Epidemiology Biomarkers & Prevention Aug 2007 111
8 Recognition and Interpretation of Polygenic Discontinuity Surfaces in the Middle Cretaceous Shu’aiba, Nahr Umr, and Natih Formations of Northern Oman Adrian Immenhauser, Anouk Creusen, Mateu Esteban et al. · GeoArabia Open access Apr 2000 96
9 Glioblastoma cell death induced by asiatic acid Chanhyeong Cho, Da-Hye Choi, Michael H. Cardone et al. · Cell Biology and Toxicology Aug 2006 71
10 Molecular Recognition by Glycoside Pseudo Base Pairs and Triples in an Apramycin–RNA Complex Qing Han, Qiang Zhao, Sarah R. Fish et al. · Angewandte Chemie International Edition 25 Apr 2005 68
11 Hydroxyquinoline-derived compounds and analoguing of selective Mcl-1 inhibitors using a functional biomarker David J. Richard, Ryan J. Lena, Thomas D. Bannister et al. · Bioorganic & Medicinal Chemistry Open access 15 Aug 2013 58
12 Mcl-1 Mediates TWEAK/Fn14-Induced Non–Small Cell Lung Cancer Survival and Therapeutic Response Timothy G. Whitsett, Ian T. Mathews, Michael H. Cardone et al. · Molecular Cancer Research Open access 28 Jan 2014 43
13 Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications Muhammad Hasan Bashari, Fengjuan Fan, Sonia Vallet et al. · Breast Cancer Research Open access 26 Feb 2016 38
14 Impact of basin burial and exhumation on Jurassic carbonates diagenesis on both sides of a thick clay barrier (Paris Basin, NE France) Cédric Carpentier, Benjamin Brigaud, Thomas Blaise et al. · Marine and Petroleum Geology Open access 22 Feb 2014 36
15 Defining specificity and on-target activity of BH3-mimetics using engineered B-ALL cell lines Brian S. Koss, Jeremy A. Ryan, Amit Budhraja et al. · Oncotarget Open access 5 Feb 2016 35
16 BH3 Profiling Discriminates Response to Cytarabine-Based Treatment of Acute Myelogenous Leukemia William E. Pierceall, Steven Mitchell Kornblau, Nicole E. Carlson et al. · Molecular Cancer Therapeutics Open access 3 Oct 2013 32
17 Combined inhibition of MDM2 and BCR-ABL1 tyrosine kinase targets chronic myeloid leukemia stem/progenitor cells in a murine model Bing Z. Carter, Po Yee Mak, Hong Hua Mu et al. · Haematologica Open access Aug 2019 27
18 Mitochondrial Profiling of Acute Myeloid Leukemia in the Assessment of Response to Apoptosis Modulating Drugs Jo Ishizawa, Kensuke Kojima, Teresa J. McQueen et al. · PLoS ONE Open access 16 Sep 2015 24
19 Sequential azacitidine plus lenalidomide in previously treated elderly patients with acute myeloid leukemia and higher risk myelodysplastic syndrome Rupa Narayan, Jacqueline Suen Garcia, Mary‐Elizabeth M. Percival et al. · Leukemia & lymphoma/Leukemia and lymphoma 16 Sep 2015 24
20 A Phase I/II Trial of Carfilzomib, Pegylated Liposomal Doxorubicin, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma Mark A. Schroeder, Mark Aaron Fiala, Eric J. Huselton et al. · Clinical Cancer Research Open access 5 Apr 2019 20
21 Rationally derived drug combinations with the novel Mcl-1 inhibitor EU-5346 in breast cancer Sonia Vallet, Fengjuan Fan, Stefano Malvestiti et al. · Breast Cancer Research and Treatment 29 Oct 2018 20
22 The Sureste Super Basin of southern Mexico Mark V. Shann, Karina Vazquez-Reyes, Hussein Mohammed Ali et al. · AAPG Bulletin 3 Dec 2020 18
23 Anti-apoptotic BCL-2 family proteins confer resistance to calicheamicin-based antibody-drug conjugate therapy of acute leukemia Colin D. Godwin, Olivia M. Bates, Sae Rin Jean et al. · Leukemia & lymphoma/Leukemia and lymphoma Open access 4 Jul 2020 15
24 High resolution ion microprobe investigation of the δ18O of carbonate cements (Jurassic, Paris Basin, France): New insights and pending questions Benoı̂t Vincent, Benjamin Brigaud, Laurent Emmanuel et al. · Sedimentary Geology 3 Feb 2017 13
25 Mcl-1 dependence predicts response to vorinostat and gemtuzumab ozogamicin in acute myeloid leukemia William E. Pierceall, Ryan J. Lena, Bruno C. Medeiros et al. · Leukemia Research Open access 28 Feb 2014 12
26 SEDIMENTOLOGY, PALAEOGEOGRAPHY AND DIAGENESIS OF THE UPPER PERMIAN (Z2) HAUPTDOLOMIT FORMATION ON THE SOUTHERN MARGIN OF THE MID NORTH SEA HIGH AND IMPLICATIONS FOR RESERVOIR PROSPECTIVITY Jo Garland, C. J. Tiltman, C. Inglis · Journal of Petroleum Geology Jul 2023 7
27 UNRAVELLING THE COMPLEXITY OF THIN (SUB‐SEISMIC) HETEROGENEOUS CARBONATE RESERVOIRS: AN INTEGRATED STUDY OF THE ALBIAN MAUDDUD FORMATION IN THE GREATER BURGAN AREA, KUWAIT Benoı̂t Vincent, Omran Al-Zankawi, I. Hayat et al. · Journal of Petroleum Geology 20 Jun 2020 7
28 Shale tectonic processes: Field evidence from the Parras Basin (north-eastern Mexico) Éric Deville, Clement Dutrannoy, Julien Schmitz et al. · Marine and Petroleum Geology Open access 8 Sep 2020 6
29 Regional Unconformities in the Cenomanian and Turonian Limestone of Southwest Iran (Sarvak Formation) - Sub-aerial Exposures, Diagenetic Patterns & Impact on Reservoir Properties Benoı̂t Vincent, Rudy Swennen, M. Jalali et al. · Proceedings Conference paperOpen access 24 Jan 2010 6
30 Depositional and diagenetic controls of carbonate reservoir property distribution in a SuperGiant reservoir, SE Iraq Benoı̂t Vincent, Francis Witkowski, Andrew D. Horbury et al. Conference paper 2019 4
31 Depositional environments and palaeogeography of the Station Quarry Beds (Brigantian), Derbyshire, England P. Gutteridge · Proceedings of the Yorkshire Geological Society Oct 1990 4
32 An introduction to ‘Carbonate Reservoirs: Applying Current Knowledge to Future Energy Needs’ Joanna Garland, Andrew Barnett, Trevor P. Burchette et al. · Geological Society London Special Publications 27 Jan 2025 3
33 Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs Andrew J. Kinloch, Faiyaz Rahman, Bahriye Karakaş et al. · Cancers Open access 31 May 2025 2
34 BH3 Profiling As Predictor Of 5-Azacytidine and Decitabine Clinical Responses Raoul Tibes, Steven Mitchell Kornblau, William E. Pierceall et al. · Blood 15 Nov 2013 2
35 Mitochondrial priming of chronic lymphocytic leukemia patients associates Bcl-xL dependence with alvocidib response William E. Pierceall, Susan Warner, Ryan J. Lena et al. · Leukemia Open access 3 Jul 2014 2
36 The role of RNA interference in drug target validation: Application to Hepatitis C Antje Ostareck‐Lederer, Sandra Clauder‐Münster, Rolf Thermann et al. · Cambridge University Press eBooks Book chapter 17 Jan 2005 2
37 About this title - Carbonate Reservoirs: Applying Current Knowledge to Future Energy Needs Joanna Garland, Andrew Barnett, Trevor P. Burchette et al. · Geological Society London Special Publications 22 Feb 2024 1
38 BH3 Profiling Predicts 5-Azacytidine Response in Malignant Myeloid Cells James M. Bogenberger, William E. Pierceall, Ryan J. Lena et al. · Blood 16 Nov 2012 1
39 Spatial Organization, Heterogeneity and Complexity of Triassic and Early Jurassic Deposystems of the Arabian Plate Andrew D. Horbury · Proceedings Conference paperOpen access 26 Jan 2015 1
40 Middle and Late Paleozoic Tectonostratigraphy of NE Offshore Abu Dhabi Salt Basin Andrew D. Horbury, C. J. Byrne, Mashkoor Malik et al. Conference paper 2025 0
41 Sedimentology and Sequence Stratigraphy of the Gotnia Formation of Kuwait P. Gutteridge, Andrew D. Horbury, Benoı̂t Vincent et al. Conference paper 2024 0
42 Shu’aiba Prospectivity in the Bab Basin: Implications for Future Exploration Nageen Sardar, M.N. Ahsan, Mashkoor Malik et al. Conference paper 2024 0
43 PCR67 A Systematic Literature Review of Health-Related Quality of Life of Patients With Advanced Esophageal Cancer Sinjitha S Nambiar, I Ferrusi, K. Rodha et al. · Value in Health ReviewOpen access Dec 2022 0
44 Nanoparticules de LiNbO3 : synthèse, propriétés ONL et nanocomposites R. Hadji, Sylvain Nguyen, B. Vincent et al. · HAL (Le Centre pour la Communication Scientifique Directe) Conference paper 23 Aug 2010 0
45 Karst and dolomitization controlling Miocene carbonate reservoir quality: Case study of carbonate oil discovery, East Java Basin, Indonesia Nuryoko Haribowo, Iko Sagala, Nadia Nurul et al. Conference paper 15 Aug 2022 0
46 How Fast-Track “Proxy” Model Improves Risk Analysis and Impacts Project Management G. Fabre, C. Rigollet, B. Vincent et al. · 83rd EAGE Annual Conference & Exhibition Conference paper 2022 0
47 12P Individualized breast cancer therapy using Mcl-1 inhibition based combination Muhammad Hasan Bashari, S. Malvestiti, F. Fan et al. · Annals of Oncology Dec 2016 0
48 iPSCs for modeling Diamond–Blackfan anemia Jingping Ge · Elsevier eBooks Book chapter 2020 0
49 Using BH3 Profiling As a Predictive Indicator for Myeloma Patient Response to Bortezomib, Michael J. Thomenius, Jan Černý, Ryan J. Lena et al. · Blood 18 Nov 2011 0
50 Petrophysical Description And Assessment Of Storage And Flow Capacity In The Triassic Kurrachine Dolomite Reservoirs Of Ash Shaer Field, Palmyra, Syria Jonathan C. Hall, Mike Millar, P. Gutteridge et al. 19 Jun 2010 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.